Related Experiment Video

Updated: Jul 13, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

An update on the management of Chagas cardiomyopathy

Manoel O C Rocha1, Mauro M Teixeira, Antonio L Ribeiro

  • 1Internal Medicine Department and Coordinator, Postgraduate Course of Tropical Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil. rochamoc@medicina.ufmg.br

Expert Review of Anti-Infective Therapy
|August 7, 2007
PubMed

Insights

Chagas disease, caused by Trypanosoma cruzi, leads to Chagas cardiomyopathy in millions. This review covers diagnosis, management, and emerging therapies for heart failure and arrhythmias, emphasizing parasite persistence.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Parasitology

Background:

  • Chagas disease, caused by Trypanosoma cruzi, affects 18 million people in Latin America.
  • It primarily targets the heart, leading to severe complications like heart failure, arrhythmias, and death.

Purpose of the Study:

  • To review the clinical diagnosis and management of Chagas cardiomyopathy.
  • To emphasize clinical staging, diagnostic tests, and individualized treatment for heart failure and arrhythmias.
  • To discuss the role of parasite persistence in pathogenesis and explore novel therapeutic approaches.

Main Methods:

  • Literature review focusing on clinical diagnosis and management strategies.
  • Analysis of diagnostic tests for individualizing treatment.
  • Discussion of current and emerging treatment modalities.

Main Results:

  • Chagas cardiomyopathy presents with significant cardiac morbidity and mortality.
  • Effective management relies on accurate clinical staging and appropriate diagnostic tools.
  • Parasite persistence is a key factor in disease progression.

Conclusions:

  • Individualized treatment strategies are crucial for managing Chagas cardiomyopathy.
  • Further research into new therapies is needed to improve patient outcomes.
  • Understanding parasite persistence is vital for developing effective interventions.

More Related Videos

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...